Skip to content

2 Top Biotech Stocks Defying The Bear Market

Investors are beginning the new year staring at a market that is already down significantly. And predictions for further losses in 2023 are plastered across a lot of headlines. The downturn has hit most industries. And biotech has been no exception. The SPDR S&P Biotech ETF is down 20% over the past year. That’s slightly worse than the total return of the S&P 500 index. 

But at least two stocks are bucking the trend. In fact, these are at their highest levels in a year. Here’s how these two biotechs are taking very different approaches to deliver for shareholders.

This post originally appeared at The Motley Fool.